-
Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic StenosisB Tamarappoo, D Han, D Berman et al. -
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJ Butler, G Filippatos, TJ Siddiqi et al.
-
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve ReplacementDD Val, M Abdel-Wahab, J Rodés-Cabau et al.
-
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic StenosisA Mentias, M Saad ,MY Desai et al.
-
Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical TrialD-W Park, J-M Ahn, D-Y Kang et al.
-
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsJK Forrest, GM Deeb, SJ Yakubov et al.
-
Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart AssociationGR Shroff , S Bangalore and On behalf of the American Heart Association Council on the Kidney in Cardiovascular Disease and Stroke Council
-
Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte ActivationS Baratchi, MTK Zaldivia, K Peter et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
